Moving to COVID-19 Vaccine Acceptance Intervention for COVID-19

Phase-Based Progress Estimates
Central Arkansas Veterans Healthcare System Eugene J. Towbin Healthcare Center, Little Rock, AR, North Little Rock, AR
COVID-19+1 More
Moving to COVID-19 Vaccine Acceptance Intervention - Behavioral
All Sexes
What conditions do you have?

Study Summary

This study is evaluating whether a set of activities can increase vaccination rates for people with traumatic brain injury.

See full description

Eligible Conditions

  • COVID-19
  • COVID19 Vaccination

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

This trial is evaluating whether Moving to COVID-19 Vaccine Acceptance Intervention will improve 1 primary outcome and 5 secondary outcomes in patients with COVID-19. Measurement will happen over the course of 18 months.

1 year
COVID-19 Vaccination Status
Seasonal Influenza Vaccination Status
Secondary Analysis of VA National Data
18 months
Qualitative Interview with purposive subset of Veterans from Intervention and Usual Care who did and did not receive COVID-19 vaccination
Qualitative Interviews with VA staff and Healthcare Providers
Survey of Veterans from Intervention and Usual Care who did and did not receive COVID-19 vaccination

Trial Safety

Trial Design

2 Treatment Groups

Usual Care Arm
1 of 2
Intervention Arm
1 of 2
Active Control
Experimental Treatment

This trial requires 2500 total participants across 2 different treatment groups

This trial involves 2 different treatments. Moving To COVID-19 Vaccine Acceptance Intervention is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.

Intervention Arm
The VAMC Internal Facilitator will partner with the trial External Facilitators (research team and designated External Facilitators in VISNS 16 and 21) to adapt and implement the study intervention to best meet the needs and preferences of their VAMC site. In addition, each CBOC and clinic affiliated with a VAMC in the Intervention arm will need to identify a Site Champion to provide clinic-specific information to facilitate implementation of the Vaccine Acceptance Intervention at their clinic or CBOC. In addition, for clinics and CBOCs assigned to the Vaccine Acceptance Intervention, VAMC, clinic and CBOC leadership will need to agree to release PACT staff for an initial two-hour Motivational Interviewing (MI) training, and at least one 60-minute post-training consultation session over the one-year trial period. There will be additional consultation sessions offered to intervention clinics and CBOC staff, but these will be optional.
Usual Care ArmA VAMC assigned to Usual Care will have no specific trial intervention requirements beyond their usual level of participation in national and local initiatives to improve COVID-19 vaccine acceptance. At both Intervention and Usual Care sites, the study team will perform quarterly "environmental scans". The environmental scan survey will include questions about site specific barriers to COVID-19 vaccination (first dose and second dose if needed), current programs/initiatives in the clinic or local community that are improving or have had no impact on vaccination rates, and the perceived importance that the VAMC/CBOC clinic staff is placing on vaccination (Environmental Scan Survey, in preparation). At Usual Care sites, a point of contact will be chosen from each clinic and CBOC to complete the environmental scan, and at Intervention sites, the Site Champion (see below) will perform the quarterly scan.

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 1 year
This trial has the following approximate timeline: 3 weeks for initial screening, variable treatment timelines, and roughly 1 year for reporting.

Closest Location

Central Arkansas Veterans Healthcare System Eugene J. Towbin Healthcare Center, Little Rock, AR - North Little Rock, AR

Eligibility Criteria

This trial is for patients born any sex aged 18 and older. There are 5 eligibility criteria to participate in this trial as listed below.

Mark “yes” if the following statements are true for you:
You have recently completed the COVID-19 vaccine if you have completed two doses of the mRNA vaccine or have completed the single-dose Janssen/Johnson & Johnson vaccine within the past 60 days. show original
The aim of this study is to conduct implementation-focused interviews with VISN 16 and 21 staff and HCPs to explore their perceptions of the impact of the VA MISSION Act on care delivery and to identify opportunities for improvement. show original
I need to go to a primary care clinic, but I'm not sure if I should go to one in VISN 16 or 21. show original
trials The company has not initiated any trials for a COVID-19 vaccine. show original
The company has initiated one of the two mRNA vaccines, but the second dose is outside of the window. show original

Patient Q&A Section

What is covid-19?

"Data from a recent study was conducted in accordance with the Declaration of Helsinki (DoH). It is the first study to provide detailed information relating to the latest outbreak of SARS-CoV-2, the new strain of coronavirus which causes the disease called coronavirus disease 2019 (COVID-19) or 2020-ncov. It will allow the global scientific community to better understand the spread of the disease. The first report on the clinical profile and outcome of patients with infection with SARS-CoV-2 have been published in the Lancet Infectious Diseases in June 2020, showing a high mortality rate of up to 35 per cent. It also has been shown to disproportionately affect certain populations." - Anonymous Online Contributor

Unverified Answer

What are common treatments for covid-19?

"Most patients with SARS had pneumonia, requiring hospitalization and some requiring intensive care. A substantial proportion of patients also developed respiratory failure. The mainstay of treatment was oxygen therapy. Other treatments such as immune-modulators and antivirals used in cases with Ebola virus infection may be used in patients with covid-19. It is important to identify and treat such patients." - Anonymous Online Contributor

Unverified Answer

What are the signs of covid-19?

"Abnormal chest X-ray, erythrocyte sedimentation rate and increased serum C-reactive protein are common and early signs of infection with SARS. Most cases of severe acute respiratory syndrome related to COVID-19 are not caused by the SARS virus itself with those viruses tending to be" - Anonymous Online Contributor

Unverified Answer

How many people get covid-19 a year in the United States?

"Approximately 2 percent of Americans are hospitalized for complications from coronavirus disease 2019 (Covid-19) infection each year. Younger people (ages <60 years old) have higher rates of serious complications from Covid-19 than older age-groups." - Anonymous Online Contributor

Unverified Answer

What causes covid-19?

"The disease was found to have many potential transmission lines; including direct or close contacts, close indoor work environments, and contaminated surfaces. Further research is needed to determine the exact transmission line of the infection." - Anonymous Online Contributor

Unverified Answer

Can covid-19 be cured?

"There are currently no treatment or cure for new onset or recurrent outbreaks of COVID-19 infection. Early diagnosis of COVID-19 relies on clinical evaluation, radiological imaging results and laboratory testing such as IgM and IgG antibodies against SARS-CoV-2 as well as a negative PCR assay. The treatment of infection consists of supportive and preventive measures. The use of an investigational drug remdesivir for the treatment of COVID-19 infection is being investigated in a clinical trial." - Anonymous Online Contributor

Unverified Answer

What is moving to covid-19 vaccine acceptance intervention?

"This RCT suggested a plausible and promising role for a brief intervention to help improve the acceptance of a future HIV/vaccine vaccination campaign. Further work is needed to assess the effect on confidence as well as acceptability of the intervention." - Anonymous Online Contributor

Unverified Answer

What are the common side effects of moving to covid-19 vaccine acceptance intervention?

"Most commonly reported side effects were minor and of short duration. Few side effects can be anticipated based on our previous knowledge of the most commonly experienced side effects of measles vaccination." - Anonymous Online Contributor

Unverified Answer

Is moving to covid-19 vaccine acceptance intervention safe for people?

"Moving to a vaccination campaign may be safe for those in the healthcare workforce at all ages. There was no increased risk of serious adverse events. All health workers should be familiarised with their personal and agency risk. We recommend vaccination of the entire population, including health workers." - Anonymous Online Contributor

Unverified Answer

What does moving to covid-19 vaccine acceptance intervention usually treat?

"The message of the moving to accept the vaccine intervention has the potential to provide an approach to improving the attitudes and intentions toward using the SARS-CoV-2 vaccine, as well as an approach to improving the acceptance that people with SARS-CoV-2 infection are contagious." - Anonymous Online Contributor

Unverified Answer

How does moving to covid-19 vaccine acceptance intervention work?

"Changing an organizational structure to offer CI was not associated with greater acceptance of PVS to the vaccine. Other interventions targeting CI should be explored and implemented." - Anonymous Online Contributor

Unverified Answer

What is the average age someone gets covid-19?

"Results from a recent paper suggests that people who are 50 years and over are most commonly affected by the disease. This age group, however, represents only one in every 10.5 people in India. More research is warranted to further understand what exactly causes people to get affected by the virus." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
See if you qualify for this trial
Get access to this novel treatment for COVID-19 by sharing your contact details with the study coordinator.